SME Times is powered by   
Search News
Just in:   • NDA show of strength: Nitish Kumar takes oath as Bihar CM for 10th time, PM Modi attends ceremony   • S. Korea to raise anti-dumping tariffs for 2 Chinese PET film companies  • Govt reviews RBI's proposal on opening foreign bank branches, Indian banks’ global expansion  • Sensex, Nifty end near record highs as financials lead rally  • Renewable energy share in India’s power mix likely to cross 35 pc by 2030 
Last updated: 27 Sep, 2014  

Value Edge launches Pharma Analytics Blog, Pharma Musings

PR Newswire | 20 May, 2013
NEW DELHI, India: Value Edge, the leading Bio-Pharma focused outsourcing research and analytics provider today announced the launch of its blog, Pharma Musings, http://blog.valuedge.com/. The blog's content will reflect the areas of Value Edge's domain expertise including Pharma Marketing Analytics, Forecasting, Social Media analysis, Data Analytics and Disease/Opportunity Area assessments.

Speaking on the occasion Rohit Anand, CEO Value Edge said "Our aim is to provide thoughtful commentary and strategic perspective on the Pharma industry based on insightful analysis. Our blog aims to be original with data and insights from our analytical team."

Currently the blog has analytical pieces on the impact of Twitter in Pharma marketing and Social media analysis of the Tecfidera launch written by the Social Media team at Value Edge. Other pieces include Alzheimer's disease and one of the demise of clinical trials in India.

The blog is interactive allowing readers to post their comments and also contains links to other powerful blogs. Over time Value Edge wants to build a digital community where the Value Edge analyst team can comment on the industry, disease or analytical approaches and the interactivity provided by the medium is used to the fullest and the blog becomes an indispensable tool for the industry.

About Value Edge

Value Edge,http://www.valuedge.com  provides "consulting grade" outsourced Analytics and Business research to global bio-pharma and medical device companies.  We approach Life sciences in a holistic fashion - we have Data analysts, Modellers, Medical Doctors, B. Pharm/M. Pharm analysts, Software engineers all housed in one company - a "hard to find combination of skill sets" to meet the unique and demanding needs of the life science industries. Currently we are supporting 2 of the top 15 Bio-Pharma companies globally with FTE based support and other top tier global companies with project based support. To learn more please look us up at http://www.valuedge.com

Contact: Rohit Anand, +91-991000-4651, rohit.anand@valuedge.com.

SOURCE Value Edge Research Services Pvt. Ltd

 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹88.70
₹87
UK Pound
₹119.90
₹116
Euro
₹104.25
₹100.65
Japanese Yen ₹59.20 ₹57.30
As on 30 Oct, 2025
  Daily Poll
Who do you think will benefit more from the India - UK FTA in the long run?
 Indian businesses & consumers.
 UK businesses & consumers.
 Both will gain equally.
 The impact will be negligible for both.
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter